Learning the fundamental immunology and immunopathology of the late 1970s in medical school was intriguing.
In those days, much to the credit of the “whole man” emphasis in the DO ethos , I was headed to be a generalist, at least as broad as a competent internist.
I got hooked on rheumatology by mavens at the Cleveland Clinic, the likes of John Clough, MD ; Art Scherbel, MD ; Alan Mackenzie, MD ; and Le o n ard H. Calabrese , DO . One barb was that these guys could convey the nuances of those weird diseases in a way that even I could grasp, while most of my contemporaries grimaced at immunologically mediated maladies and held them at arm’s length.
Another barb was that the therapeutic armamentarium was narrow enough, then, that I could imagine t